Stanford University: Clinical Trials & Research Profile
Academic / Cooperative Group (Stanford, CA) · Primary Focus: Rare Genetic, Women's Health, and Other
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Academic / Cooperative Group (Stanford, CA) |
| Primary Therapeutic Area | Rare Genetic, Women's Health, and Other |
| Active Phase II & III Studies | 69 active (49 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 139 (134 with California sites) |
| Completed vs Early-Stopped Studies | 39 completed / 30 stopped (21.6% stop rate) |
| Median Closed Enrollment | 30 participants |
| FDA Drugs@FDA Original Approvals | 0 all-time (0 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 100.0% named hospital slots |
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk